In addition, IGF-1 LR3 may promote fat breakdown by activating the MAPK pathway, leading to increased levels of free fatty acids and further exacerbating insulin resistance, forming a vicious cycle
Monitoring key clinical parameters is essential
Evaluation of the main hypotheses underpinning the life extension effects of CR using the hepatic transcriptome
Weight loss medications Anti-obesity medications including GlP-1 agonists such as liraglutide (eg Saxenda), semaglutide (eg Wegovy), could be considered (off -licensed) with the right support, in addition to active lifestyle intervention, for the management of weight for PCOS
At the lower doses used for diabetes, they have somewhat lower rates of diarrhea (9-12% for Ozempic, 12-21% for Mounjaro) compared to their weight management counterparts